Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies

It's a test of CEO Bill Anderson's development credentials as patent expiries on blockbuster drugs threaten the group's ...

Bayer moves Parkinson's cell therapy into Phase III trial

Bayer has started the third phase of human testing of an experimental stem cell therapy for Parkinson's disease, with future ...
TipRanks on MSN

Shilpa Medicare Secures EMA Approval for Rivaroxaban Orodispersible Films

Shilpa Medicare Limited ( ($IN:SHILPAMED) ) has shared an update. Shilpa Medicare Limited has received initial authorization from the European ...

Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 1:10 PM EDTCompany ParticipantsTom Cavanaugh - ...

10 Major Medicare Changes Coming in 2026: What to Expect with Premiums, Drug Prices, and Program Cuts

Medicare beneficiaries face higher premiums and deductibles, reduced services, and possible cuts to the program at large—but ...
Oil

Phillips 66 to take full ownership of Wood River, Borger refineries

Phillips 66 will pay $1.4 billion to acquire Cenovus's 50% stake in WRB Refining, ending a nearly 20-year joint venture. Full ownership of Wood River and Borger refineries will increase Phillips 66’s ...
Yahoo! Sports

MLB playoffs 2025 tracker: Yankees tie Blue Jays atop AL East, Guardians take AL Central lead, Mariners win AL West — standings, schedule, clinch scenarios with 4 games to go

The MLB regular season is approaching the finish line and the race to the postseason gave us a dramatic shakeup in the AL East and AL Central. Before diving deep into a breakdown of the playoff ...